Goldman Sachs Group, Inc. (The) vs Markel Group Inc. — Stock Comparison
Q·Score Breakdown
6.9
Neutral
Overall
4.8
Bearish
Quality
Health
Growth
Valuation
Sentiment
GS
Earnings growing 24% year-over-year on 14% revenue growth.
⚠ cautious analyst consensus — few Buy ratings.
MKL
Forward P/E of 14.3× is low relative to sector peers.
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
HOLD
Target $935.10 (+1.2%)
20 analysts
HOLD
Target $2005.40 (+12.7%)
5 analysts
Fundamentals
GS
MKL
16.9×
Trailing P/E
12.9×
14.1×
Forward P/E
14.3×
29.4%
Profit Margin
11.1%
82.3%
Gross Margin
49.3%
14.5%
ROE
10.0%
14.5%
Revenue Growth
-16.9%
24.2%
Earnings Growth
—
1.31
Beta
0.79
—
Price / Book
—
$274.1B
Market Cap
$22.3B
$547 – $985
52-Week Range
$1,719 – $2,208
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →